Takahiko Kurasawa Selected Research

Takahiko Kurasawa Research Topics

9	Rheumatoid Arthritis 01/2021 - 10/2011
3	Vasculitis (Vasculitides) 01/2021 - 10/2017
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 10/2017
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2019 - 10/2017
2	Lupus Nephritis 01/2013 - 01/2013
1	Type IV Ehlers-Danlos Syndrome 01/2022
1	Blood Vessel Dissection 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2021
1	Giant Cell Arteritis (Horton Disease) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Hemorrhage 01/2021
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2021
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2020
1	Glomerulonephritis 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Microscopic Polyangiitis 10/2017
1	Rheumatic Diseases (Rheumatism) 06/2016
1	Hyperuricemia 01/2013
1	Adult-Onset Still's Disease 03/2012
1	Arthralgia (Joint Pain) 03/2012
1	Fever (Fevers) 03/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012
1	Immunoglobulin G4-Related Disease 01/2012
1	Drug-Related Side Effects and Adverse Reactions 10/2011
1	Pneumonia (Pneumonitis) 10/2011

8	tocilizumab (atlizumab)FDA Link 01/2020 - 10/2011
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 01/2013
3	Infliximab (Remicade)FDA Link 06/2016 - 07/2014
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 01/2020
2	GlucocorticoidsIBA 01/2020 - 01/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 06/2016 - 03/2012
2	Methotrexate (Mexate)FDA LinkGeneric 06/2016 - 07/2014
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	VaccinesIBA 01/2021
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	BNT162 VaccineIBA 01/2021
1	Rheumatoid FactorIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	C-Reactive ProteinIBA 01/2021
1	IntegrinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2020
1	InterleukinsIBA 01/2020
1	Etanercept (Enbrel)FDA Link 10/2015
1	CytokinesIBA 10/2015
1	Antirheumatic Agents (DMARD)IBA 07/2014
1	Tumor Necrosis Factor InhibitorsIBA 05/2014
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2014
1	EnzymesIBA 01/2013
1	mizoribineIBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2013
1	Adalimumab (Humira)FDA Link 06/2012
1	Ferritins (Ferritin)IBA 03/2012
1	Immunoglobulin G (IgG)IBA 01/2012

4	Therapeutics 05/2018 - 01/2012